Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial-Reference-Cited by-同舟云学术

Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial

Published:2015-06-05 Issue:13 Volume:75 Page:1403-1418
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Winchester Danyelle A.¹,Till Cathee²,Goodman Phyllis J.²,Tangen Catherine M.²,Santella Regina M.³,Johnson-Pais Teresa L.⁴,Leach Robin J.⁴,Xu Jianfeng⁵,Zheng S. Lilly⁵⁶,Thompson Ian M.⁴,Lucia M. Scott⁷,Lippmann Scott M.⁸,Parnes Howard L.⁹,Dluzniewski Paul J.¹,Isaacs William B.¹⁰¹¹,De Marzo Angelo M.¹⁰¹¹¹²,Drake Charles G.¹⁰¹¹¹³,Platz Elizabeth A.¹¹⁰¹¹

Affiliation:

1. Department of Epidemiology; Johns Hopkins Bloomberg School of Public Health; Baltimore Maryland

2. SWOG Statistical Center; Fred Hutchinson Cancer Research Center; Seattle Washington

3. Department of Environmental Health Sciences, Mailman School of Public Health; Columbia University; New York New York

4. Department of Urology; University of Texas Health Science Center San Antonio; San Antonio Texas

5. Program for Personalized Cancer Care and Department of Surgery; NorthShore University Health System; Evanston Illinois

6. Center for Cancer Genomics; Wake Forest University School of Medicine; Winston-Salem North Carolina

7. Department of Pathology; University of Colorado Denver School of Medicine; Aurora Colorado

8. Moores Cancer Center; University of California San Diego; La Jolla California

9. Prostate and Urologic Cancer Research Group; Division of Cancer Prevention, National Cancer Institute; Bethesda Maryland

10. Department of Urology, and James Buchanan Brady Urological Institute; Johns Hopkins University School of Medicine; Baltimore Maryland

11. Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Baltimore Maryland

12. Department of Pathology; Johns Hopkins University School of Medicine; Baltimore Maryland

13. Department of Immunology; Johns Hopkins University School of Medicine; Baltimore Maryland

Funder

Public Health Service

National Cancer Institute

Publisher

Wiley

Subject

Urology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pros.23021/fullpdf

Reference41 articles.

1. Prostate cancer and inflammation: The evidence;Sfanos;Histopathology,2012

2. Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial;Gurel;Cancer Epidemiol Biomarkers Prev,2014

3. The influence of finasteride on the development of prostate cancer;Thompson;N Engl J Med,2003

4. A comprehensive association study for genes in inflammation pathway provides support for their roles in prostate cancer risk in the CAPS study;Zheng;Prostate,2006

5. Cumulative association of five genetic variants with prostate cancer;Zheng;N Engl J Med,2008

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of TLR4 gene 2026A/G (rs1927914), 896A/G (rs4986790), and 1196C/T (rs4986791) polymorphisms and cancer susceptibility: Meta-analysis and trial sequential analysis;Medicine;2023-02-22

2. Inflammatory metabolic profile of South African patients with prostate cancer;Cancer & Metabolism;2021-08-03

3. Association of IL2-330 Gene Polymorphism with Lung Cancer;Phoenix Medical Journal;2021-06-08

4. Evidence from 40 Studies that 2 Common Single-Nucleotide Polymorphisms (SNPs) of RNASEL Gene Affect Prostate Cancer Susceptibility: A Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)-Compliant Meta-Analysis;Medical Science Monitor;2019-11-05

5. Protective Innate Immune Variants in Racial/Ethnic Disparities of Breast and Prostate Cancer;Cancer Immunology Research;2019-09